7th Annual Forum on Patient Adherence, Compliance and Persistency
April 21 – 22, 2008 * Location TBD
For more information or to register, please visit the conference website.
The pharmaceutical industry continues to face major obstacles in attaining patient persistency and compliance. The related cost is $100 billion, according to PharmaCentra, which also indicates that healthcare management is shifting to more effective delivery models to more effectively manage the problems. (PharmaVoice, June 2007).
CBI and PharmaVoice’s 2nd annual ‘Strategic Patient Adherence” (SPA) Awards produced two winners from Astrazeneca for the Best Integrated and Amgen/Walgreens for Best Branded Program. The Best Integrated Award Program was presented to Cadient Group for Astrazeneca’s The Bipolar Adherence Program for SEROQUEL and the Best Branded Program was presented to Amgen/Walgreen’s for their Persistency Program for Sensipar®. These two programs won because our esteemed group of judges deemed them exceptional in their compliance initiatives.
Please click here for PharmaVoice’s coverage on the 2007 SPA Awards
Please do not miss the opportunity to celebrate your compliance successes in 2008.
For more information regarding the awards and submission guidelines please email: email@example.com.
Over 150 executives attended the 2007 event. Do not miss the leading patient compliance event for 2008! Discussions include impact of benefits design, concrete tools for evaluating data and determining ROI and bridging reimbursement gaps to improve persistence. The 2008 program features the key stakeholders and the most up-to-date information on improving product utilization through patient compliance.
For more information or to register, please please visit the conference website or contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at firstname.lastname@example.org.